Chiome Bioscience (4583.T) Stock Price

Chiome Bioscience Price

CLOSED
94.00
​
Market closed

Revenue has compounded at 21.8% per year over the past 19 years to 593.29 M JPY. Chiome Bioscience's net margin stands at -165.6%, up from -207.6% several years earlier.

Chiome Bioscience stock price

Access this data via the Eulerpool API

Chiome Bioscience business model & stock analysis

Chiome Bioscience, Inc. engages in the development and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) system. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 49 full-time employees. The company went IPO on 2011-12-20. The firm operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.

Frequently asked questions about Chiome Bioscience

Converted at the current exchange rate, the Chiome Bioscience share trades at 0.53 EUR (94.00 JPY).

The revenue cannot currently be calculated for Chiome Bioscience.

The profit cannot currently be calculated for Chiome Bioscience.

The P/E ratio cannot be calculated for Chiome Bioscience at the moment.

The P/S cannot be calculated for Chiome Bioscience currently.

The Eulerpool Quality Score for Chiome Bioscience is 3/10.

The ISIN of Chiome Bioscience is JP3205350006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Chiome Bioscience is 4583.T. The ticker symbol is used to trade Chiome Bioscience shares on the stock exchange.

Fair ValueTerminal
97.76 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
12.11 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website chiome.co.jp
Country
Currency
JPY
Initial public offering
Dec 20, 2011
ISIN
JP3205350006
Cusip
J0645U104
Market capitalization
6.53 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/Se
—
EV/EBIT
—
P/B Ratio
5.82
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-71.02 %
Last updated Oct 10, 2026, 5:53 PM

Chiome Bioscience Peer Group

Chiome Bioscience FIGI

4583:JP · BBG00283XKK74583:JT · BBG00283XKL64583:JJ · BBG00283XKW44583:JE · BBG00283XL074583:JI · BBG00283XL164583:JU · BBG002QKJK344583:JW · BBG00875LBJ54583:JV · BBG0193RCRL0